168 related articles for article (PubMed ID: 20006646)
1. Implication of 5-HT2 receptor subtypes in the mechanism of action of the GABAergic compound etifoxine in the four-plate test in Swiss mice.
Bourin M; Hascoët M
Behav Brain Res; 2010 Apr; 208(2):352-8. PubMed ID: 20006646
[TBL] [Abstract][Full Text] [Related]
2. Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test-retest paradigm in mice.
Ripoll N; Hascoët M; Bourin M
Behav Brain Res; 2006 Jan; 166(1):131-9. PubMed ID: 16154212
[TBL] [Abstract][Full Text] [Related]
3. Anxiolytic-like effect of 5-HT(2) ligands and benzodiazepines co-administration: comparison of two animal models of anxiety (the four-plate test and the elevated plus maze).
Massé F; Nic Dhonnchadha BA; Hascoët M; Bourin M
Behav Brain Res; 2007 Feb; 177(2):214-26. PubMed ID: 17175036
[TBL] [Abstract][Full Text] [Related]
4. Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats.
Ugale RR; Sharma AN; Kokare DM; Hirani K; Subhedar NK; Chopde CT
Brain Res; 2007 Dec; 1184():193-201. PubMed ID: 17950705
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety.
Nic Dhonnchadha BA; Bourin M; Hascoët M
Behav Brain Res; 2003 Mar; 140(1-2):203-14. PubMed ID: 12644293
[TBL] [Abstract][Full Text] [Related]
6. Effect of GABAergic ligands on the anxiolytic-like activity of DOI (a 5-HT(2A/2C) agonist) in the four-plate test in mice.
Massé F; Hascoët M; Bourin M
Eur Neuropsychopharmacol; 2007; 17(6-7):483-91. PubMed ID: 17196374
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice.
Nic Dhonnchadha BA; Hascoët M; Jolliet P; Bourin M
Behav Brain Res; 2003 Dec; 147(1-2):175-84. PubMed ID: 14659583
[TBL] [Abstract][Full Text] [Related]
8. Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A/2C agonists) in the four-plate test.
Massé F; Hascoët M; Dailly E; Bourin M
Psychopharmacology (Berl); 2006 Jan; 183(4):471-81. PubMed ID: 16307296
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the GABA
Mattei C; Taly A; Soualah Z; Saulais O; Henrion D; Guérineau NC; Verleye M; Legros C
Pharmacol Res; 2019 Jul; 145():104250. PubMed ID: 31059790
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
[TBL] [Abstract][Full Text] [Related]
11. The anxiolytic etifoxine protects against convulsant and anxiogenic aspects of the alcohol withdrawal syndrome in mice.
Verleye M; Heulard I; Gillardin JM
Alcohol; 2009 May; 43(3):197-206. PubMed ID: 19393860
[TBL] [Abstract][Full Text] [Related]
12. Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test.
Nic Dhonnchadha BA; Ripoll N; Clénet F; Hascoët M; Bourin M
Psychopharmacology (Berl); 2005 May; 179(2):418-29. PubMed ID: 15821956
[TBL] [Abstract][Full Text] [Related]
13. Brain structures implicated in the four-plate test in naïve and experienced Swiss mice using injection of diazepam and the 5-HT2A agonist DOI.
Petit-Demoulière B; Massé F; Cogrel N; Hascoët M; Bourin M
Behav Brain Res; 2009 Dec; 204(1):200-5. PubMed ID: 19523493
[TBL] [Abstract][Full Text] [Related]
14. Anxiolytic-like effects observed in rats exposed to the elevated zero-maze following treatment with 5-HT2/5-HT3/5-HT4 ligands.
Bell R; Duke AA; Gilmore PE; Page D; Bègue L
Sci Rep; 2014 Jan; 4():3881. PubMed ID: 24457553
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of etifoxine on anxiety-like behaviour and convulsions in BALB/cByJ and C57BL/6J mice: any relation to overexpression of central GABAA receptor beta2 subunits?
Verleye M; Dumas S; Heulard I; Krafft N; Gillardin JM
Eur Neuropsychopharmacol; 2011 Jun; 21(6):457-70. PubMed ID: 20943351
[TBL] [Abstract][Full Text] [Related]
16. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E
J Pharm Pharmacol; 2005 Feb; 57(2):253-7. PubMed ID: 15720791
[TBL] [Abstract][Full Text] [Related]
17. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A
Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
[TBL] [Abstract][Full Text] [Related]
18. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
Gomes KS; Nunes-De-Souza RL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the serotonergic system in the anxiolytic-like effect caused by m-trifluoromethyl-diphenyl diselenide in mice.
Brüning CA; Prigol M; Roehrs JA; Nogueira CW; Zeni G
Behav Brain Res; 2009 Dec; 205(2):511-7. PubMed ID: 19683021
[TBL] [Abstract][Full Text] [Related]
20. In Vitro and In Vivo Neuroprotective Effects of Etifoxine in β-Amyloidinduced Toxicity Models.
Riban V; Meunier J; Buttigieg D; Villard V; Verleye M
CNS Neurol Disord Drug Targets; 2020; 19(3):227-240. PubMed ID: 32479250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
